Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma - Poll - MDSpire

Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma

  • By

  • Dan Xu

  • Daqing Huang

  • Zhijie Li

  • Yan Yan

  • Zhencun Cui

  • Zhongfang Zhao

  • Xiaoju Chen

  • Maolong Chen

  • Xiongxiong Liu

  • Zhaobo Zhou

  • Qianxi Ni

  • Taofeng Zhang

  • Hui Wang

  • Qi Zeng

  • Xi’an Xiong

  • Bin Liu

  • July 14, 2026

Share

Original Source(s)

Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma

  • by Dan Xu, Daqing Huang, Zhijie Li, Yan Yan, Zhencun Cui, Zhongfang Zhao, Xiaoju Chen, Maolong Chen, Xiongxiong Liu, Zhaobo Zhou, Qianxi Ni, Taofeng Zhang, Hui Wang, Qi Zeng, Xi’an Xiong, Bin Liu

  • July 14, 2026

Related Content

Diagnostic research in immune checkpoint inhibitor-related pneumonitis: a bibliometric analysis of research evolution, diagnostic focuses, and future priorities

Designing and conducting interventional trials with passive-sensing applications on patient-owned smartphones: challenges and recommendations from the BD4QoL study

Late radiation necrosis following stereotactic radiosurgery after COVID-19 vaccination: a case report and hypothesis of immune-mediated inflammatory activation